Business Wire
18 Jul 2026, 02:16 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
The Schall Law Firm is soliciting lead plaintiffs for a securities fraud lawsuit against Regeneron Pharmaceuticals, Inc. — Class action fraud allegations can create short-term downward pressure on stock prices and increase the perceived legal risk profile of the company.
-0.30Which stocks this story touches
The company is the target of a securities fraud lawsuit.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
2h ago
